BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37430314)

  • 1. Randomized double-blind personalized N-of-1 clinical trial to test the safety and potential efficacy of TJ-68 for treating muscle cramps in amyotrophic lateral sclerosis (ALS): study protocol for a TJ-68 trial.
    Mitsumoto H; Cheung K; Oskarsson B; Andrews HF; Jang GE; Andrews JA; Shah JS; Fernandes JA; McElhiney M; Santella RM
    Trials; 2023 Jul; 24(1):449. PubMed ID: 37430314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial.
    Weber M; Goldman B; Truniger S
    J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1135-40. PubMed ID: 20498181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium for skeletal muscle cramps.
    Garrison SR; Korownyk CS; Kolber MR; Allan GM; Musini VM; Sekhon RK; Dugré N
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD009402. PubMed ID: 32956536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel muscle cramp scale (MCS) in amyotrophic lateral sclerosis (ALS).
    Mitsumoto H; Chiuzan C; Gilmore M; Zhang Y; Ibagon C; McHale B; Hupf J; Oskarsson B
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Aug; 20(5-6):328-335. PubMed ID: 31007059
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease.
    Baldinger R; Katzberg HD; Weber M
    Cochrane Database Syst Rev; 2012 Apr; (4):CD004157. PubMed ID: 22513921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open-label pilot study of ranolazine for cramps in amyotrophic lateral sclerosis.
    Chandrashekhar S; Hamasaki AC; Clay R; McCalley A; Herbelin L; Pasnoor M; Jawdat O; Dimachkie MM; Barohn RJ; Statland J
    Muscle Nerve; 2022 Jul; 66(1):71-75. PubMed ID: 35466411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
    ;
    Lancet Neurol; 2017 Jul; 16(7):505-512. PubMed ID: 28522181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression.
    Weiss MD; Macklin EA; Simmons Z; Knox AS; Greenblatt DJ; Atassi N; Graves M; Parziale N; Salameh JS; Quinn C; Brown RH; Distad JB; Trivedi J; Shefner JM; Barohn RJ; Pestronk A; Swenson A; Cudkowicz ME;
    Neurology; 2016 Apr; 86(16):1474-81. PubMed ID: 26911633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ropinirole hydrochloride remedy for amyotrophic lateral sclerosis - Protocol for a randomized, double-blind, placebo-controlled, single-center, and open-label continuation phase I/IIa clinical trial (ROPALS trial).
    Morimoto S; Takahashi S; Fukushima K; Saya H; Suzuki N; Aoki M; Okano H; Nakahara J
    Regen Ther; 2019 Dec; 11():143-166. PubMed ID: 31384636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study): Study protocol clinical trial (SPIRIT Compliant).
    Vucic S; Ryder J; Mekhael L; Rd H; Mathers S; Needham M; Dw S; Mc K;
    Medicine (Baltimore); 2020 Feb; 99(6):e18904. PubMed ID: 32028398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial.
    Urbi B; Broadley S; Bedlack R; Russo E; Sabet A
    BMJ Open; 2019 Nov; 9(11):e029449. PubMed ID: 31719072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Study of Muscle Cramps in ALS in the USA.
    Stephens HE; Joyce NC; Oskarsson B
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):32-36. PubMed ID: 27978764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of mexiletine in amyotrophic lateral sclerosis: a systematic review of randomized controlled trials.
    Adiao KJB; Espiritu AI; Bagnas MAC
    Neurodegener Dis Manag; 2020 Dec; 10(6):397-407. PubMed ID: 32867586
    [No Abstract]   [Full Text] [Related]  

  • 14. Mecasin treatment in patients with amyotrophic lateral sclerosis: study protocol for a randomized controlled trial.
    Kim S; Kim JK; Son MJ; Kim D; Song B; Son I; Kang HW; Lee J; Kim S
    Trials; 2018 Apr; 19(1):225. PubMed ID: 29653550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
    Oki R; Izumi Y; Fujita K; Miyamoto R; Nodera H; Sato Y; Sakaguchi S; Nokihara H; Kanai K; Tsunemi T; Hattori N; Hatanaka Y; Sonoo M; Atsuta N; Sobue G; Shimizu T; Shibuya K; Ikeda K; Kano O; Nishinaka K; Kojima Y; Oda M; Komai K; Kikuchi H; Kohara N; Urushitani M; Nakayama Y; Ito H; Nagai M; Nishiyama K; Kuzume D; Shimohama S; Shimohata T; Abe K; Ishihara T; Onodera O; Isose S; Araki N; Morita M; Noda K; Toda T; Maruyama H; Furuya H; Teramukai S; Kagimura T; Noma K; Yanagawa H; Kuwabara S; Kaji R;
    JAMA Neurol; 2022 Jun; 79(6):575-583. PubMed ID: 35532908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial.
    Lombardo FL; Spila Alegiani S; Mayer F; Cipriani M; Lo Giudice M; Ludolph AC; McDermott CJ; Corcia P; Van Damme P; Van den Berg LH; Hardiman O; Nicolini G; Vanacore N; Dickie B; Albanese A; Puopolo M;
    Trials; 2023 Dec; 24(1):792. PubMed ID: 38053196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.
    Abdul Wahid SF; Law ZK; Ismail NA; Lai NM
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011742. PubMed ID: 31853962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis.
    James E; Ellis C; Brassington R; Sathasivam S; Young CA
    Cochrane Database Syst Rev; 2022 May; 5(5):CD006981. PubMed ID: 35593746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Japanese Early-Stage Trial of High-Dose Methylcobalamin for Amyotrophic Lateral Sclerosis (JETALS): Protocol for a Randomized Controlled Trial.
    Oki R; Izumi Y; Nodera H; Sato Y; Nokihara H; Kanai K; Sonoo M; Urushitani M; Nishinaka K; Atsuta N; Kohara N; Shimizu T; Kikuchi H; Oda M; Ikeda K; Nagai M; Komai K; Kojima Y; Kuzume D; Isose S; Shimohama S; Abe K; Ito H; Noda K; Ishihara T; Morita M; Shimohata T; Teramukai S; Kagimura T; Noma K; Yanagawa H; Kuwabara S; Kaji R;
    JMIR Res Protoc; 2018 Dec; 7(12):e12046. PubMed ID: 30578206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of muscle cramps in amyotrophic lateral sclerosis.
    Caress JB; Ciarlone SL; Sullivan EA; Griffin LP; Cartwright MS
    Muscle Nerve; 2016 Apr; 53(4):513-7. PubMed ID: 26332705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.